LUNG CANCER PANEL 7 (EGFR, BRAF, ALK1, ROS1, MET) (SDL11828)
https://www.scanlabglobal.com/shop/sdl11828-lung-cancer-panel-7-egfr-braf-alk1-ros1-met-sdl11828-6217
https://www.scanlabglobal.com/web/image/product.template/6217/image_1920?unique=18393fc
Analyzes EGFR, BRAF, ALK, ROS1, MET for NSCLC therapy. Mutations guide dabrafenib or MET inhibitors for personalized treatment.
%20(SDL11828)?unique=89ca60f)